Abstract
Beads of gentamicin-polymethylmethacrylate (Septopal), each containing 4.5 mg of gentamicin base, were implanted intraperitoneally in rats. Each rat received one bead. Serum levels and urinary excretion of gentamicin were maximal in the first day of treatment (0.6 micrograms/ml in serum 3 h after implantation of the bead and 525 micrograms per 24-h urine sample) and decreased thereafter. Kidney cortical concentrations of gentamicin progressively increased and peaked after 4 days, reaching 117 micrograms/g. Tissue levels decreased thereafter in spite of the persistence of the drug in urine, and this occurred in the absence of cell damage leading to cell death. Release of gentamicin from intact proximal tubular cells, despite continuous uptake, prevented intracellular drug concentrations from reaching a nephrotoxic level. This experimental study provides a rational basis for the previous clinical observation that nephrotoxicity due to treatment with gentamicin-polymethylmethacrylate beads is improbable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronoff G. R., Pottratz S. T., Brier M. E., Walker N. E., Fineberg N. S., Glant M. D., Luft F. C. Aminoglycoside accumulation kinetics in rat renal parenchyma. Antimicrob Agents Chemother. 1983 Jan;23(1):74–78. doi: 10.1128/aac.23.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fabre J., Rudhardt M., Blanchard P., Regamey C. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int. 1976 Dec;10(6):444–449. doi: 10.1038/ki.1976.131. [DOI] [PubMed] [Google Scholar]
- Giuliano R. A., Paulus G. J., Verpooten G. A., Pattyn V. M., Pollet D. E., Nouwen E. J., Laurent G., Carlier M. B., Maldague P., Tulkens P. M. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int. 1984 Dec;26(6):838–847. doi: 10.1038/ki.1984.226. [DOI] [PubMed] [Google Scholar]
- Giuliano R. A., Verpooten G. A., Pollet D. E., Verbist L., Scharpé S. L., De Broe M. E. Improved procedure for extracting aminoglycosides from renal cortical tissue. Antimicrob Agents Chemother. 1984 Jun;25(6):783–784. doi: 10.1128/aac.25.6.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giuliano R. A., Verpooten G. A., Verbist L., Wedeen R. P., De Broe M. E. In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther. 1986 Feb;236(2):470–475. [PubMed] [Google Scholar]
- Hedström S. A., Lidgren L., Törholm C., Onnerfält R. Antibiotic containing bone cement beads in the treatment of deep muscle and skeletal infections. Acta Orthop Scand. 1980 Dec;51(6):863–869. doi: 10.3109/17453678008990886. [DOI] [PubMed] [Google Scholar]
- Jenny G., Kempf I., Jaeger J. H., Konsbruck R. Utilisation de billes de ciment acrylique à la gentamycine dans le traitement de l'infection osseuse. Rev Chir Orthop Reparatrice Appar Mot. 1977 Jul-Aug;63(5):491–500. [PubMed] [Google Scholar]
- Josepovitz C., Pastoriza-Munoz E., Timmerman D., Scott M., Feldman S., Kaloyanides G. J. Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations. J Pharmacol Exp Ther. 1982 Nov;223(2):314–321. [PubMed] [Google Scholar]
- Kaloyanides G. J., Pastoriza-Munoz E. Aminoglycoside nephrotoxicity. Kidney Int. 1980 Nov;18(5):571–582. doi: 10.1038/ki.1980.175. [DOI] [PubMed] [Google Scholar]
- Schentag J. J., Jusko W. J., Plaut M. E., Cumbo T. J., Vance J. W., Abrutyn E. Tissue persistence of gentamicin in man. JAMA. 1977 Jul 25;238(4):327–329. [PubMed] [Google Scholar]
- Thompson W. L., Powell S. Aminoglycoside nephrotoxicity in dogs: dependence on drug, dose and regimen. Scand J Infect Dis Suppl. 1980;Suppl 23:91–95. [PubMed] [Google Scholar]